Advertisement
Feature Article

Aortic stenosis: update on transcatheter aortic valve implantation

PAUL BAMFORD, ROBERTO SPINA

Figures

© LISA CLARK, 2016
© LISA CLARK, 2016

Abstract

Aortic stenosis (AS) is the third most common cardiovascular disease in the West and primarily occurs from the narrowing of the aortic valve. There are several treatment options available for patients with AS including balloon aortic valvuloplasty and surgical aortic valve replacement. However, there is growing clinical evidence that transcatheter aortic valve implantation (TAVI) may be the superior alternative to open heart surgery in intermediate and high-risk patients.

Key Points

  • Aortic stenosis is a common cardiovascular disease that accounts for significant morbidity and mortality if left untreated
  • Transcatheter aortic valve implantation (TAVI) provides an excellent alternative to open heart surgery in intermediate- and high-risk patients
  • Patients with surgical prosthetic valve failure are usually eligible for transcatheter valve-in-valve replacement
  • Balloon aortic valvuloplasty provides patients with a bridge to definitive treatment

Figures

© LISA CLARK, 2016
© LISA CLARK, 2016